LAMOND DAVID purchased 3.0% of their position (67.88K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $69.2K — a small addition. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 12/14/2023ACC: 0001209191-23-058694
+67.88K
Net shares
Net buyer
$69.2K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
67.88K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+300.00
Price / share
$1.00
Trade value
$300.00
% of position
0.0%
12/12/2023
2.28M→2.28M
Common Stock
Direct
Shares
+22.33K
Price / share
$1.02
Trade value
$22.77K
% of position
1.0%
12/12/2023
2.28M→2.30M
Common Stock
Indirect
Shares
+22.63K
Price / share
$1.00
Trade value
$22.63K
% of position
1.0%
12/13/2023
2.30M→2.32M
Common Stock
Indirect
Shares
+22.63K
Price / share
$1.04
Trade value
$23.53K
% of position
1.0%
12/14/2023
2.32M→2.35M
Total
Net shares
+67.88K
Net value
$69.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/12/2023 | P · Purchase | +300.00 | $1.00 | $300.00 | 0.0% | 2.28M | 2.28M |
| Common Stock Direct | 12/12/2023 | P · Purchase | +22.33K | $1.02 | $22.77K | 1.0% | 2.28M | 2.30M |
| Common Stock Indirect | 12/13/2023 | P · Purchase | +22.63K | $1.00 | $22.63K | 1.0% | 2.30M | 2.32M |
| Common Stock Indirect | 12/14/2023 | P · Purchase | +22.63K | $1.04 | $23.53K | 1.0% | 2.32M | 2.35M |
| Total | +67.88K | $69.23K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.73M
Common Stock
DirectShares owned301.83K
Total
301.83K direct·1.73M indirect2.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.73M | Indirect |
| Common Stock | 301.83K | Direct |
| Total | 2.04M | 301.83K direct·1.73M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported